| |
|
| |
 |
Dictionary |
 |
| Furosemide related compound b (100 mg) (4-chloro-5-sulfamoylanthranilic acid) |
| Gadoteridol related compound a (50 mg) (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodode-cane-1,4,7-triacetic acid) |
| Gadoteridol related compound b (50 mg) (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt) |
| Gadoteridol related compound c (50 mg) (1,4,7,10-tetraaza-11-oxo-bicyclo[8.2.2]tetrade-cane-4,7-diacetic acid) |
| Glimepiride related compound c (20 mg) (glimepiride urethane) |
| 5-Desmethyl-6-methyl glipizide |
| Glyburide related compound b (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (as) |
| (9Z,12z)-octadeca-9,12-dienoic acid, monoester with glycerol |
| 2-[(E)-(1-benzyl-4-piperidinyl)methylidene]-5,6-dimethoxy-1-indanone |
| N-[(1r,3r,5s)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1h-indazole-3-carboxamide hydrochloride |
|
|
|
Dictionary |
|
|
| Chemical Name: |
10-Formylfolic acid (25 mg) |
| Synonyms: |
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methyl-formyl-amino]benzoyl]amino]pentanedioic acid;Linearolactone; |
| CAS#: |
134-05-4 |
| Molecular formula: |
C20H19N7O7 |
| Molecular weight: |
469.4076 |
| Molecular Structure: |
 |
|
|
